MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/105/0.1/20.09.24 | Real-time Bid/Ask 13:17:32 2024-07-01 EDT | ||
| 3.93 EUR / 3.94 EUR | +4.65% |
|
| Current month | +29.21% | ||
| 1 month | +28.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 3.71 | -1.33% |
| 24-06-28 | 3.76 | -1.05% |
| 24-06-27 | 3.8 | +0.26% |
| 24-06-26 | 3.79 | -5.49% |
| 24-06-25 | 4.01 | +11.70% |
Delayed Quote Börse Stuttgart
Last update July 01, 2024 at 08:50 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | ME1GAE |
| ISIN | DE000ME1GAE6 |
| Date issued | 2023-10-03 |
| Strike | 105 $ |
| Maturity | 2024-09-20 (81 Days) |
| Parity | 10 : 1 |
| Emission price | 0.75 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.01 € |
|---|---|
| Lowest since issue | 0.52 € |
| Delta | 0.97x |
| Omega | 3.332 |
| Premium | 1.1x |
| Gearing | 3.44x |
| Moneyness | 1.388 |
| Difference Strike | -40.63 $ |
| Difference Strike % | -38.70% |
| Spread | 0.01 € |
| Spread % | 0.25% |
| Theoretical value | 3.955 |
| Implied Volatility | 39.39 % |
| Total Loss Probability | 4.055 % |
| Intrinsic value | 3.813 |
| Present value | 0.1421 |
| Break even | 147.44 € |
| Theta | -0.02x |
| Vega | 0x |
| Rho | 0.02x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006
DKK
Average target price
949.7
DKK
Spread / Average Target
-5.56%
- Stock Market
- Warrants
- Warrant
